BridgeBio Pharma Inc (BBIO)
23.20
-0.04
(-0.19%)
USD |
NASDAQ |
Nov 22, 13:42
BridgeBio Pharma 1 Year Total Returns (Daily): -17.91% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | -17.91% |
November 20, 2024 | -21.20% |
November 19, 2024 | -22.94% |
November 18, 2024 | -23.59% |
November 15, 2024 | -19.65% |
November 14, 2024 | -18.22% |
November 13, 2024 | -9.92% |
November 12, 2024 | -9.15% |
November 11, 2024 | -3.62% |
November 08, 2024 | -7.83% |
November 07, 2024 | -11.94% |
November 06, 2024 | -8.14% |
November 05, 2024 | -11.48% |
November 04, 2024 | -12.59% |
November 01, 2024 | -4.39% |
October 31, 2024 | -10.10% |
October 30, 2024 | -6.74% |
October 29, 2024 | 0.25% |
October 28, 2024 | 0.00% |
October 25, 2024 | -2.42% |
October 24, 2024 | -3.59% |
October 23, 2024 | 0.87% |
October 22, 2024 | 1.51% |
October 21, 2024 | 2.40% |
October 18, 2024 | -0.23% |
Date | Value |
---|---|
October 17, 2024 | -2.20% |
October 16, 2024 | 1.66% |
October 15, 2024 | -2.68% |
October 14, 2024 | -1.15% |
October 11, 2024 | -2.81% |
October 10, 2024 | -5.95% |
October 09, 2024 | -8.71% |
October 08, 2024 | -2.10% |
October 07, 2024 | -1.66% |
October 04, 2024 | 5.04% |
October 03, 2024 | 0.79% |
October 02, 2024 | -1.30% |
October 01, 2024 | -5.95% |
September 30, 2024 | -3.45% |
September 27, 2024 | -5.32% |
September 26, 2024 | -7.90% |
September 25, 2024 | -9.49% |
September 24, 2024 | -8.84% |
September 23, 2024 | -6.86% |
September 20, 2024 | -3.57% |
September 19, 2024 | -4.66% |
September 18, 2024 | -9.04% |
September 17, 2024 | -8.24% |
September 16, 2024 | -10.09% |
September 13, 2024 | -7.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.69%
Minimum
Jun 13 2022
543.5%
Maximum
Dec 27 2023
48.03%
Average
49.77%
Median
1 Year Total Returns (Daily) Benchmarks
Alnylam Pharmaceuticals Inc | 50.78% |
Pfizer Inc | -12.01% |
Vertex Pharmaceuticals Inc | 26.94% |
PTC Therapeutics Inc | 96.29% |
Bristol-Myers Squibb Co | 26.16% |